期刊
ADVANCED SCIENCE
卷 10, 期 22, 页码 -出版社
WILEY
DOI: 10.1002/advs.202300656
关键词
CRISmers; CRISPR; Cas; RNA aptamers; SARS-CoV-2
RNA aptamers are useful biological probes and therapeutic agents. CRISmers is a CRISPR/Cas-based screening system for identifying specific aptamers targeting SARS-CoV-2 variants. The study demonstrates that aptamers selected by CRISmers show sensitive detection and potent neutralization of SARS-CoV-2, both in vitro and in vivo. The findings highlight the robustness, consistency, and potential broad utility of CRISmers.
RNA aptamers provide useful biological probes and therapeutic agents. New methodologies to screen RNA aptamers will be valuable by complementing the traditional Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Meanwhile, repurposing clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated systems (Cas) has expanded their utility far beyond their native nuclease function. Here, CRISmers, a CRISPR/Cas-based novel screening system for RNA aptamers based on binding to a chosen protein of interest in a cellular context, is presented. Using CRISmers, aptamers are identified specifically targeting the receptor binding domain (RBD) of the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Two aptamer leads enable sensitive detection and potent neutralization of SARS-CoV-2 Delta and Omicron variants in vitro. Intranasal administration of one aptamer, further modified with 2'-fluoro pyrimidines (2'-F), 2'-O-methyl purines (2'-O), and conjugation with both cholesterol and polyethylene glycol of 40 kDa (PEG40K), achieves effective prophylactic and therapeutic antiviral activity against live Omicron BA.2 variants in vivo. The study concludes by demonstrating the robustness, consistency, and potential broad utility of CRISmers using two newly identified aptamers but switching CRISPR, selection marker, and host species.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据